Article
Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation.
British journal of clinical pharmacology - 1 Jul 2018
Nava Tiago, Kassir Nastya, Rezgui Mohamed Aziz, Uppugunduri Chakradhara Rao Satyanarayana, Huezo-Diaz Curtis Patricia, Duval Michel, Théoret Yves, Daudt Liane E, Litalien Catherine, Ansari Marc, Krajinovic Maja, Bittencourt Henrique
Abstract excerpt
AIMS: The aim of this study is to develop a population pharmacokinetic (PopPK) model for intravenous busulfan in children that incorporates variants of GSTA1, gene coding for the main enzyme in busulfan metabolism. METHODS: Busulfan concentration-time data was collected from 112 children and adolescents (median 5.4 years old, range: 0.1-20) who received intravenous busulfan during the conditioning regimen prior...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
